XOLAIR
XOLAIR (omalizumab) is a monoclonal antibody that helps decrease allergic responses in the body. Specifically, it is an anti-IgE antibody used for asthma and chronic idiopathic urticaria (hives).
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
What it treats
Moderate to severe persistent Asthma &
Chronic Idiopathic Urticaria (Hives)
Prescribed by
Pulmonologists & Allergists
How it’s administered
Subcutaneous injection
Frequency
Every two to four weeks
Length of treatment
10 minutes or less